To Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers, and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.

Clinical trial NCT04495322 · COMPLETED

Trial details

NCT number: NCT04495322
Sponsor: TaiGen Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Chinese Volunteers

Start date: 2020-07-17
Primary completion: 2020-11-26
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.